Q2 2023 Holdings
Filed 2023-08-14 | 59 holdings | $269.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Lilly ELI & Co(LLY) | UNIT | 532457108 | $25.5M | 54,369 | 9.5% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $21.1M | 127,362 | 7.8% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $17.1M | 1,039,474 | 6.4% |
| West Pharmaceutical Svsc Inc(WST) | COM | 955306105 | $15.5M | 40,558 | 5.8% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $14.8M | 20,644 | 5.5% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $14.4M | 200,080 | 5.3% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $14.2M | 160,660 | 5.3% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $9.8M | 96,274 | 3.6% |
| Catalent Inc(CTLTEUR) | COM | 148806102 | $8.7M | 200,997 | 3.2% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $8.7M | 24,597 | 3.2% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $8.3M | 1,105,770 | 3.1% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $8.1M | 116,768 | 3.0% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $8.0M | 4,099,943 | 3.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $7.7M | 40,832 | 2.8% |
| Dexcom Inc(DXCM) | COM | 252131107 | $6.7M | 51,798 | 2.5% |
| Inari MED Inc(NARIUSD) | COM | 45332Y109 | $6.6M | 113,441 | 2.5% |
| Silk RD MED Inc | COM | 82710M100 | $6.5M | 198,532 | 2.4% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $6.0M | 26,010 | 2.2% |
| Stevanato Group S P A(STVN) | ORD SHS | T9224W109 | $5.7M | 176,359 | 2.1% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $5.6M | 297,807 | 2.1% |
| Praxis Precision Medicines I | COM | 74006W108 | $5.6M | 4,884,621 | 2.1% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $5.6M | 29,506 | 2.1% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $3.4M | 331,992 | 1.3% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $3.2M | 151,194 | 1.2% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $3.1M | 165,897 | 1.2% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $3.1M | 370,877 | 1.1% |
| Merus N V | COM | N5749R100 | $2.7M | 101,691 | 1.0% |
| Natera Inc(NTRA) | COM | 632307104 | $2.6M | 52,964 | 1.0% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $2.0M | 202,406 | 0.8% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $1.9M | 57,800 | 0.7% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $1.9M | 224,074 | 0.7% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $1.7M | 108,928 | 0.6% |
| Mersana Therapeutics Inc | COM | 59045L106 | $1.4M | 428,307 | 0.5% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $1.3M | 41,292 | 0.5% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $991.7K | 158,413 | 0.4% |
| Immatics N.v(IMTX) | SHS | N44445109 | $946.9K | 82,052 | 0.4% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $932.5K | 24,221 | 0.3% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $932.2K | 33,750 | 0.3% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $874.4K | 24,201 | 0.3% |
| Schrodinger Inc(SDGR) | COM | 80810D103 | $821.8K | 16,462 | 0.3% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $791.9K | 66,885 | 0.3% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $772.9K | 70,588 | 0.3% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $613.0K | 73,067 | 0.2% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $396.4K | 15,268 | 0.1% |
| Fibrogen Inc(FGENEUR)Put | COM | 31572Q808 | $330.8K | 122,500 | 0.1% |
| Amphenol Corp New(APH) | CL A | 032095101 | $223.3K | 2,629 | 0.1% |
| Dover Corp(DOV) | COM | 260003108 | $223.2K | 1,512 | 0.1% |
| Hartford Finl Svcs Group Inc(HIG) | COM | 416515104 | $218.5K | 3,034 | 0.1% |
| Prudential Finl Inc(PRU) | COM | 744320102 | $217.3K | 2,463 | 0.1% |
| Colgate Palmolive Co(CL) | COM | 194162103 | $208.1K | 2,701 | 0.1% |